Tango Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNGX and other ETFs, options, and stocks.About TNGX
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need.
CEOBarbara L. Weber
CEOBarbara L. Weber
Employees155
Employees155
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2017
Founded2017
Employees155
Employees155
TNGX Key Statistics
Market cap1.43B
Market cap1.43B
Price-Earnings ratio-11.53
Price-Earnings ratio-11.53
Dividend yield—
Dividend yield—
Average volume3.68M
Average volume3.68M
High today$10.81
High today$10.81
Low today$10.51
Low today$10.51
Open price$10.56
Open price$10.56
Volume307.17K
Volume307.17K
52 Week high$11.20
52 Week high$11.20
52 Week low$1.03
52 Week low$1.03
Stock Snapshot
As of today, Tango Therapeutics(TNGX) shares are valued at $10.61. The company's market cap stands at 1.43B, with a P/E ratio of -11.53.
During the trading session on 2025-11-26, Tango Therapeutics(TNGX) shares reached a daily high of $10.81 and a low of $10.51. At a current price of $10.61, the stock is +0.9% higher than the low and still -1.9% under the high.
Trading activity shows a volume of 307.17K, compared to an average daily volume of 3.68M.
Over the past 52 weeks, Tango Therapeutics(TNGX) stock has traded between a high of $11.20 and a low of $1.03.
Over the past 52 weeks, Tango Therapeutics(TNGX) stock has traded between a high of $11.20 and a low of $1.03.
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own TNGX. This list is generated using Robinhood data, and it’s not a recommendation.